Adaptimmune MAGE

Clinical Trial Grant

Duke Scholars

Principal Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Adaptimmune Limited

Start Date

January 11, 2018

End Date

June 19, 2020

Administered By

Duke Cancer Institute

Awarded By

Adaptimmune Limited

Start Date

January 11, 2018

End Date

June 19, 2020